Voyager Therapeutics Inc
VYGR
Market Cap$402.91M
Close$
$12.45
60.2% upside
Current Fair Value
60.2% upsideUndervalued by 60.2% based on the discounted cash flow analysis.
Share Statistics
| Market cap | $402.91 Million |
|---|---|
| Enterprise Value | $172.04 Million |
| Dividend Yield | $0.0 (0.0%) |
| Earnings per Share | $2.97 |
| Beta | 0.0 |
| Outstanding Shares | 54,300,627 |
| Avg 30 Day Volume | 579,455 |
Return
| Return on Equity | - |
|---|---|
| Return on Assets | - |
| Return on Invested Capital | - |
Valuation & Multiples
| P/E Ratio | 3.04 |
|---|---|
| PEG | -0.9 |
| Price to Sales | 1.94 |
| Price to Book Ratio | 1.94 |
| Enterprise Value to Revenue | 0.69 |
| Enterprise Value to EBIT | 1.41 |
| Enterprise Value to Net Income | 1 |
| Total Debt to Enterprise | 0 |
| Debt to Equity | 0 |
Revenue Sources
No data
ESG Score
No data
About Voyager Therapeutics Inc
CEO: G. Andre Turenne